Novo Nordisk
NVO
#117
Rank
S$217.85 B
Marketcap
S$49.35
Share price
0.89%
Change (1 day)
-36.28%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2026 (TTM): S$29.88 Billion

According to Novo Nordisk's latest financial reports the company's current earnings are S$51.22 Billion. In 2025 the company made an earning of S$26.85 Billion, an increase over its 2024 earnings that were of S$25.26 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$29.88 B11.28%
2025 S$26.85 B6.28%
2024 S$25.26 B28.01%
2023 S$19.73 B57.81%
2022 S$12.50 B5.24%
2021 S$11.88 B12.38%
2020 S$10.57 B13.11%
2019 S$9.35 B-3.45%
2018 S$9.68 B1.88%
2017 S$9.50 B4.3%
2016 S$9.11 B10.32%
2015 S$8.26 B7.47%
2014 S$7.68 B3.4%
2013 S$7.43 B19.09%
2012 S$6.24 B15.58%
2011 S$5.40 B16.58%
2010 S$4.63 B25.66%
2009 S$3.68 B10.68%
2008 S$3.33 B55.82%
2007 S$2.13 B7.02%
2006 S$1.99 B19.05%
2005 S$1.67 B10.55%
2004 S$1.51 B
2002 S$1.02 B-14.39%
2001 S$1.19 B-52.82%
2000 S$2.53 B250%
1999 S$0.72 B31.21%
1998 S$0.55 B34.31%
1997 S$0.41 B11.46%
1996 S$0.36 B9.03%
1995 S$0.33 B-3.15%
1994 S$0.34 B-0.67%
1993 S$0.35 B45.38%
1992 S$0.24 B-13.81%
1991 S$0.28 B37.12%
1990 S$0.20 B-0.79%
1989 S$0.20 B26.2%
1988 S$0.16 B24.97%
1987 S$0.13 B-0.9%
1986 S$0.13 B-7.78%
1985 S$0.14 B24.87%
1984 S$0.11 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
S$8.84 B-70.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$43.04 B 44.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$9.17 B-69.16%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
S$15.25 B-48.71%๐Ÿ‡บ๐Ÿ‡ธ USA